MDT

98.04

-0.23%↓

VEEV

301.51

-1.09%↓

A

142.09

+2.42%↑

HQY

91.65

+4.35%↑

PHR.US

23.47

-0.34%↓

MDT

98.04

-0.23%↓

VEEV

301.51

-1.09%↓

A

142.09

+2.42%↑

HQY

91.65

+4.35%↑

PHR.US

23.47

-0.34%↓

MDT

98.04

-0.23%↓

VEEV

301.51

-1.09%↓

A

142.09

+2.42%↑

HQY

91.65

+4.35%↑

PHR.US

23.47

-0.34%↓

MDT

98.04

-0.23%↓

VEEV

301.51

-1.09%↓

A

142.09

+2.42%↑

HQY

91.65

+4.35%↑

PHR.US

23.47

-0.34%↓

MDT

98.04

-0.23%↓

VEEV

301.51

-1.09%↓

A

142.09

+2.42%↑

HQY

91.65

+4.35%↑

PHR.US

23.47

-0.34%↓

Search

NeoGenomics Inc

Atvērts

9.31 3.56

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

8.96

Max

9.45

Galvenie mērījumi

By Trading Economics

Ienākumi

-19M

-45M

Pārdošana

13M

181M

Peļņas marža

-24.867

Darbinieki

2,200

EBITDA

-41M

-48M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+18.16% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 28. okt.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

344M

1.2B

Iepriekšējā atvēršanas cena

5.75

Iepriekšējā slēgšanas cena

9.31

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bearish Evidence

NeoGenomics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 30. sept. 14:35 UTC

Galvenie tirgus virzītāji

Robo.ai Shares Rise After $300 Million Investment From Burkhan Capital

2025. g. 7. okt. 15:15 UTC

Tirgus saruna

Investors Look to Gold, Bitcoin as Traditional Correlations Break Down -- Market Talk

2025. g. 7. okt. 12:33 UTC

Iegādes, apvienošanās, pārņemšana

NYSE Owner to Invest Up to $2 Billion in Polymarket -- WSJ

2025. g. 7. okt. 12:32 UTC

Iegādes, apvienošanās, pārņemšana

NYSE Owner to Invest Up to $2 Billion in Polymarket -- WSJ

2025. g. 7. okt. 11:53 UTC

Tirgus saruna

Central Banks Could Add Bitcoin to Reserves -- Market Talk

2025. g. 7. okt. 08:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2025. g. 7. okt. 07:00 UTC

Tirgus saruna

Bitcoin Eases After Hitting Fresh Record High -- Market Talk

2025. g. 6. okt. 10:14 UTC

Tirgus saruna

Bitcoin Could Extend Gains on U.S. Government Shutdown -- Market Talk

2025. g. 6. okt. 07:18 UTC

Tirgus saruna

Market Talk Roundup: Latest on U.S. Politics

2025. g. 6. okt. 07:18 UTC

Tirgus saruna

Bitcoin Stays Stronger After Hitting Record High -- Market Talk

2025. g. 3. okt. 13:10 UTC

Tirgus saruna

Bitcoin Looks Ripe For Fresh Record High -- Market Talk

2025. g. 3. okt. 07:20 UTC

Tirgus saruna

Bitcoin Pulls Back as Government Shutdown Delays Key Data -- Market Talk

2025. g. 2. okt. 13:17 UTC

Iegādes, apvienošanās, pārņemšana

Bitcoin Depot: Acquisition Had No Material Impact on Reported 3Q Preliminary Results >BTM

2025. g. 2. okt. 13:16 UTC

Iegādes, apvienošanās, pārņemšana

Bitcoin Depot: Acquisition Brings U.S. Market Share to Roughly 30% >BTM

2025. g. 2. okt. 13:16 UTC

Iegādes, apvienošanās, pārņemšana

Bitcoin Depot: Acquisition Adds Over 500 Kiosks to Network >BTM

2025. g. 2. okt. 13:15 UTC

Iegādes, apvienošanās, pārņemšana

Bitcoin Depot Acquires Assets of National Bitcoin ATM, Significantly Expanding U.S. Footprint

2025. g. 2. okt. 07:05 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 2. okt. 07:05 UTC

Tirgus saruna

Bitcoin Rises Following Wall Street Rally -- Market Talk

2025. g. 1. okt. 23:12 UTC

Iegādes, apvienošanās, pārņemšana

Avalanche Treasury CEO is Bart Smith

2025. g. 1. okt. 23:11 UTC

Iegādes, apvienošanās, pārņemšana

Avalanche Treasury Investors Include Dragonfly, VanEck, Galaxy Digital and Others

2025. g. 1. okt. 23:07 UTC

Iegādes, apvienošanās, pārņemšana

Avalanche Treasury Plans to Own More Than $1B Worth of AVAX After Becoming a Public Company

2025. g. 1. okt. 23:06 UTC

Iegādes, apvienošanās, pārņemšana

Avalanche Treasury Co. Has an Exclusive Relationship With Avalanche Foundation

2025. g. 1. okt. 23:04 UTC

Iegādes, apvienošanās, pārņemšana

Avalanche Treasury: Transaction Includes About $460M in Treasury Assets

2025. g. 1. okt. 14:01 UTC

Tirgus saruna

Bitcoin Rises as Weak Jobs Data Boost Rate-Cut Bets -- Market Talk

2025. g. 1. okt. 07:27 UTC

Tirgus saruna

Bitcoin Edges Lower as U.S. Government Shut Down Begins -- Market Talk

2025. g. 30. sept. 14:20 UTC

Galvenie tirgus virzītāji

Robo.ai Shares Rise After $300M Investment From Burkhan Capital

2025. g. 30. sept. 06:51 UTC

Tirgus saruna

Bitcoin Eases as Possible U.S. Government Shutdown Looms -- Market Talk

2025. g. 29. sept. 13:48 UTC

Tirgus saruna

Seasonality Could Favor Bitcoin in Coming Months -- Market Talk

2025. g. 29. sept. 07:40 UTC

Tirgus saruna

Bitcoin Recovers But Remains at Risk of Renewed Losses -- Market Talk

2025. g. 26. sept. 07:29 UTC

Tirgus saruna

Bitcoin Stabilizes After Steep Falls; Focus Turns to U.S. PCE Data -- Market Talk

Salīdzinājums

Cenas izmaiņa

NeoGenomics Inc Prognoze

Cenas mērķis

By TipRanks

18.16% augšup

Prognoze 12 mēnešiem

Vidējais 10.67 USD  18.16%

Augstākais 14 USD

Zemākais 8 USD

Pamatojoties uz 11 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi NeoGenomics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

11 ratings

5

Pirkt

6

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

7.7 / 10.27Atbalsts un pretestība

Īstermiņā

Very Strong Bearish Evidence

Vidējā termiņā

Bearish Evidence

Ilgtermiņā

Bearish Evidence

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
help-icon Live chat